Kyle Guse - 02 Mar 2023 Form 4 Insider Report for ATOSSA THERAPEUTICS, INC. (ATOS)

Signature
/s/ Kyle Guse
Issuer symbol
ATOS
Transactions as of
02 Mar 2023
Net transactions value
$0
Form type
4
Filing time
06 Mar 2023, 15:10:36 UTC
Previous filing
28 Feb 2022
Next filing
15 Aug 2025

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATOS Stock Option (right to buy) Award $0 +557,900 $0.000000 557,900 02 Mar 2023 Common Stock 557,900 $0.7200 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest and become exercisable on a quarterly basis over 24 months from the grant-date.